404
Clinical Microbiology Market Analysis | 2022-2028
Clinical Microbiology Market Size, Share, Trends, Dynamics, Forecasts, Industry and Growth Analysis (2022-2028)
Clinical Microbiology Market is segmented by Product Type (Instruments [Laboratory Instruments and Microbiology Analyzers] and Reagents [Pathogen-specific Kits and General Reagents]), by Disease Type (Respiratory Diseases, Bloodstream Infections, Gastrointestinal Diseases, Sexually Transmitted Diseases, Urinary Tract Infections, Periodontal Diseases, and Other Diseases), by End-User Type (Hospitals & Diagnostic Centers, Custom Lab Service Providers, and Academic & Research Institutes), and by Region (North America, Europe, Asia-Pacific, and Rest of the World).
Clinical microbiology is a branch of medical science which focuses on the isolation and characterization of infectious organisms, in order to manage and treat them in patients. This subject of microbiology is concerned with the prevention, diagnosis, and treatment of infectious diseases.
The clinical microbiology market was estimated to grow from USD 3.96 Billion in 2021 to USD 6.18 Billion by 2028.
The clinical microbiology market is expected to grow at a CAGR of 6.52% during the forecast period.
Some of the major players in the market are- Abbott Laboratories, Agilent Technologies, Inc., Becton Dickinson and Company, Bio-Rad Laboratories, Inc., Bruker Corporation, Danaher Corporation, Hologic, Inc., Neogen Corporation, The 3M Company, The Merck Group.
North America is expected to be the leading region in the market over the forecast period.
Some of the key factors driving the growth of the clinical microbiology market are technological advancements, rising incidence of infectious diseases and pandemic outbreaks (such as COVID-19), and increased funding and public-private partnerships.